Combination compound for contraception based on natural estrogen

US6133251A · kind A · utility

Assignee

• Jenapharm GmbH & Co. KG · DE

Inventors

• Michael Dittgen · Apolda, DE
• Sabine Fricke · Jena, DE
• Herbert Hoffmann · Jena, DE
• Claudia Moore · Jena, DE
• Michael Oettel · Jena, DE
• Monika Ostertag · Göttingen, DE

Key dates

• Filing date: Oct 25, 1996
• Grant date: Oct 17, 2000
• Expiry date: Oct 25, 2016

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P15/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The combination preparation for contraception includes a first stage of 2 to 4 first stage daily dosage portions, a second stage of two groups of second stage daily dosage portions, a third stage of 2 to 4 third stage daily dosage portions and an additional stage of 2 to 4 additional stage daily dosage portions. The first stage daily dosage portion is an effective amount of natural estrogen, the second stage daily dosage portion is an effective amount of a combination of natural estrogen and natural or synthetic gestogen, the third stage daily dosage portion is another effective amount of natural estrogen and an additional stage daily dosage portion consists of a placebo. The first group of the second stage consists of 3 to 5 daily dosage portions and the second group, 13 to 17 daily dosage portions. More of the gestogen is included in the effective amount in the second group of the second stage than in the first group. The effective amount of the natural estrogen is constant in both the first and third stages, but smaller in the third stage than in the first stage.